Panagora Asset Management’s TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share TLGA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,933
Closed -$3K 2673
2021
Q2
$3K Buy
+3,933
New +$2.53K ﹤0.01% 2604

Other funds holding TLGA.WS

Panagora Asset Management's TLGA.WS Position: Q3 2021 in Review

Panagora Asset Management sold out of TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share (TLGA.WS) in Q3 2021, closing a stake of 3,933 shares — an estimated $3K sold.

Panagora Asset Management first reported a position in TLGA.WS in Q2 2021 and held it in 1 quarter. The position peaked at $3K in Q2 2021. 45 funds tracked by Wall St. Rank hold TLGA.WS as of Q3 2021.

  • Panagora Asset Management reported no remaining TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 3,933 TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q3 2021, an estimated $3K.
  • Panagora Asset Management first reported a position in TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 1 quarter.
  • Panagora Asset Management's TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $3K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.